Travel disruptions stemming from the West Asia conflict continue to weigh on India's medical tourism sector, with overseas patient inflows yet to return to earlier levels. According to reports from The Times of India, the region accounts for a substantial share of overseas patients visiting India's nearly ₹74,000 crore medical tourism market. Although hospital operators have begun to see early signs of improvement from the region, international patient arrivals remain below the levels recorded before the conflict escalated earlier this year.
Fortis Healthcare faces significant exposure to the West Asia market, with the region accounting for the largest share of its international business at 30%. As reported by The Times of India, group COO Anil Vinayak explained that "during the first two-three days after the war began, the impact was not immediately evident, as many patients had already travelled to India. However, new patient arrivals dropped sharply in March before slowly recovering in April and May." The healthcare company observes that the ongoing crisis had a visible impact on international patient movement, particularly from key markets in the Gulf and neighbouring regions.
Healthcare companies have cautioned that the prolonged geopolitical turmoil could also lead to higher operating costs, adding further pressure on the sector. According to reports from The Times of India, this additional cost burden could impact the competitiveness of India's medical tourism industry, which has been recovering from previous challenges. The sector's resilience in the face of multiple geopolitical disruptions continues to be tested by ongoing regional conflicts.
